Vuzix Corporation — Q1 2023 Form 10-Q
Business context and period: Vuzix designs, manufactures and sells smart glasses and augmented-reality display products, and provides waveguide engineering services. This unaudited report covers the three months ended March 31, 2023, compared with Q1 2022.
Financial performance and liquidity
- Revenue: Product sales were $4.19 million, up 67% from $2.50 million. Management attributed the increase mainly to higher M400 smart-glasses unit sales. No engineering-services revenue was recorded in Q1 2023.
- Gross profit and margin: Gross profit was $876,000 versus $476,000; gross margin was 21%, up from 19%. Management cited improved overhead as a percentage of sales, although lower-than-planned production output and supply-chain issues increased unapplied manufacturing overhead.
- Operating results: Operating expenses were $11.72 million, up 8%, and operating loss widened to $10.85 million from $10.41 million. Net loss was $10.24 million, compared with $10.51 million; loss per share was $0.16 in both periods. Q1 2023 included $696,000 of investment income, versus $6,000 a year earlier, largely reflecting higher interest rates on excess cash.
- Cash flow: Operating activities used $4.16 million, compared with $6.44 million in Q1 2022. Investing activities used $4.69 million, including manufacturing expansion spending and a $2.0 million payment toward a technology-license commitment. Financing activities used $471,000, primarily for share repurchases. Cash decreased $9.33 million during the quarter.
- Cash, liquidity and debt: Cash and cash equivalents were $63.24 million at quarter-end, down from $72.56 million at December 31, 2022. Working capital was $67.05 million. The company reported no current or long-term debt obligations other than $9.5 million of current licensing-fee commitments. Lease liabilities were also reported.
- Balance-sheet and expense items: Total assets were $122.47 million and stockholders’ equity was $109.38 million. Depreciation and amortization in operating expenses rose to $964,000 from $259,000, primarily due to amortization of technology licenses associated with the Atomistic Agreements. Stock-based compensation totaled $3.67 million.
Material changes versus Q1 2022
- Revenue rose 67%, while gross margin improved by 2 percentage points. Product costs increased 71%, faster than sales, and manufacturing output was affected by supply-chain issues.
- Operating loss worsened by $433,000, including higher selling and marketing costs and substantially higher license amortization. Increased investment income more than offset this deterioration in comparing net losses.
- Cash used in operations decreased, but investing cash outflow increased materially, reflecting waveguide-facility expansion and licensing payments.
- Customer concentration increased: one customer represented 74% of Q1 2023 product revenue, versus 11% in Q1 2022; one customer accounted for 50% of receivables at March 31, 2023.
Outlook, commentary and risks
- The filing provides no specific revenue, earnings or margin guidance. Management said the new facility was expected to be completed by the end of May 2023; the filing reports approximately $165,000 of remaining revenue under a waveguide development project, expected to be recognized in Q2 2023.
- Management said supply-chain issues that constrained production had improved significantly in Q2. The company’s stated cash requirements include operating losses, working capital, research and development, capital expenditures and licensing commitments.
- Key risks include customer concentration and order timing, dependence on suppliers and manufacturing capacity, competition and rapid technological change, product acceptance, demand forecasting, and the ability to fund operations and investment needs. Management cautioned that actual results may differ materially from forward-looking statements.
- The company reported no material legal proceedings and no material changes to the risk factors in its 2022 Form 10-K. Management concluded disclosure controls were effective as of March 31, 2023; it reported no materially affecting changes to internal control during the quarter.
- The share-buyback program expired March 2, 2023. Vuzix repurchased 115,000 shares during the quarter for an average $4.06 per share. The filing also notes up to $34.1 million of potential additional non-cash LTIP compensation expense if currently unprobable operational milestones become probable or are achieved.
Important facts for investors to verify
- Whether the Q1 sales increase is sustainable, given that one customer generated 74% of product revenue.
- Whether production and supply constraints improved as management stated, and whether facility expansion is completed and productive as expected.
- Cash-burn and investment spending trends, including the timing and settlement of the remaining $9.5 million licensing-fee commitment.
- Gross-margin progression, especially product costs and unapplied manufacturing overhead as production volumes change.
- The timing and probability of LTIP milestones and the related potential compensation expense.